Top Dog Pet Store marketed Green Magic and Bulldog Cartel Parvo Combat as unapproved animal drugs for treating diseases.
What happened
FDA reviewed the company's website in May 2024 and found Green Magic and Bulldog Cartel Parvo Combat offered for sale with claims to treat or prevent diseases such as parvovirus, distemper, kennel cough, pneumonia, mastitis, coccidia, and giardia. FDA also cited similar claims on Instagram posts and product labeling.
What FDA found
The products are drugs because the website and social media claims say they treat or prevent diseases in animals.
section 201(g)(1) of the FD&C Act [21 U.S.C. 321(g)(1)]The products are new animal drugs that are not generally recognized as safe and effective for their labeled uses.
section 201(v) of the FD&C Act [21 U.S.C. 321(v)]The products lack an approved or conditionally approved application or index listing required for legal marketing.
sections 512, 571, and 572 of the FD&C Act [21 U.S.C. 360b, 360ccc, and 360ccc-1]Because they are not approved or index listed, FDA calls them unsafe and adulterated.
section 512(a) and section 501(a)(5) of the FD&C Act [21 U.S.C. 360b(a), 351(a)(5)]The products are misbranded because they have not been drug listed with FDA.
section 502(o) of the FD&C Act [21 U.S.C. 352(o)]Introducing or delivering these products into interstate commerce is prohibited.
section 301(a) of the FD&C Act [21 U.S.C. 331(a)]
What FDA wants
Within 15 working days of receipt, notify FDA in writing of the specific steps taken to address the violations and prevent recurrence, with related documentation. If correction cannot be completed in that time, state the reason and the time when it will be completed; if the company believes there is no violation, give reasoning and supporting information.
Who should pay attention
- pet owners who buy animal health products online
- veterinarians and pet breeders who recommend or use such products
- online retailers and marketplaces selling pet supplements with disease claims
This is a summary. Read the original letter on fda.gov.